Scientia Vascular promotes Paul Fischer to Chief Commercial Officer

Scientia Vascular, an emerging company in the neurovascular medical technology sector based in West Valley City, Utah, announces the promotion of Paul Fischer to the position of Chief Commercial Officer. This appointment comes during a phase of commercial success and growth for the company. With 11 years of leadership experience in sales and marketing, including as an Officer in the United States Marine Corps and executive roles at Boston Scientific and Medtronic, Fischer brings key expertise to guide Scientia Vascular towards new horizons of innovation and a stronger focus on patient outcomes.

John Lippert, CEO of Scientia Vascular, highlights the significance of Fischer's experience, also recognized by healthcare professionals for his commitment to patient care. Fischer expresses his enthusiasm for his new role, emphasizing the impressive progress made by Scientia Vascular in the field. He is preparing to lead the company's commercial team towards continued growth and the creation of new value for clients, patients, and society.

Scientia Vascular is renowned for its innovation in the neurovascular medical device industry, committed to pushing the boundaries of possible treatments for brain diseases.